Elevation Oncology Inc (ELEV)
3.93
+0.11
(+2.88%)
USD |
NASDAQ |
May 03, 12:28
Elevation Oncology Price: 3.93 for May 3, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 02, 2024 | 3.73 | 4.14 | 3.180 | 3.82 | 1.939M |
| May 01, 2024 | 3.59 | 4.48 | 3.43 | 4.00 | 2.660M |
| Apr 30, 2024 | 3.79 | 4.06 | 3.55 | 3.55 | 2.039M |
| Apr 29, 2024 | 3.65 | 3.885 | 3.51 | 3.85 | 629550.0 |
| Apr 26, 2024 | 3.68 | 3.83 | 3.57 | 3.62 | 872578.0 |
| Apr 25, 2024 | 3.89 | 3.92 | 3.46 | 3.645 | 1.231M |
| Apr 24, 2024 | 4.29 | 4.345 | 3.88 | 3.88 | 658115.0 |
| Apr 23, 2024 | 4.06 | 4.49 | 4.06 | 4.32 | 327435.0 |
| Apr 22, 2024 | 3.80 | 4.10 | 3.70 | 4.05 | 500444.0 |
| Apr 19, 2024 | 4.00 | 4.07 | 3.75 | 3.80 | 990269.0 |
| Apr 18, 2024 | 4.11 | 4.155 | 3.96 | 4.01 | 318956.0 |
| Apr 17, 2024 | 4.37 | 4.37 | 4.07 | 4.14 | 495296.0 |
| Apr 16, 2024 | 4.48 | 4.525 | 4.15 | 4.39 | 788270.0 |
| Apr 15, 2024 | 4.73 | 4.87 | 4.38 | 4.43 | 610374.0 |
| Apr 12, 2024 | 4.92 | 4.92 | 4.50 | 4.73 | 618144.0 |
| Apr 11, 2024 | 4.65 | 4.98 | 4.61 | 4.94 | 374968.0 |
| Apr 10, 2024 | 4.59 | 4.67 | 4.51 | 4.60 | 253500.0 |
| Apr 09, 2024 | 4.68 | 4.75 | 4.535 | 4.71 | 449201.0 |
| Apr 08, 2024 | 4.86 | 4.882 | 4.401 | 4.64 | 775093.0 |
| Apr 05, 2024 | 5.14 | 5.14 | 4.59 | 4.91 | 1.083M |
| Apr 04, 2024 | 5.25 | 5.59 | 4.81 | 5.06 | 1.205M |
| Apr 03, 2024 | 5.00 | 5.830 | 4.975 | 5.17 | 2.052M |
| Apr 02, 2024 | 4.99 | 5.21 | 4.88 | 5.13 | 3.448M |
| Apr 01, 2024 | 5.19 | 5.21 | 4.78 | 4.99 | 399393.0 |
| Mar 28, 2024 | 5.04 | 5.26 | 4.922 | 5.13 | 438351.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.38
Minimum
Nov 10 2023
16.11
Maximum
Jul 12 2021
3.308
Average
2.06
Median
Mar 22 2023
Price Benchmarks
| Merrimack Pharmaceuticals Inc | 15.00 |
| Mersana Therapeutics Inc | 3.50 |
| Equillium Inc | 1.68 |
| Monopar Therapeutics Inc | 0.6699 |
| Larimar Therapeutics Inc | 7.535 |
Price Related Metrics
| Price to Book Value | 3.488 |
| Earnings Yield | -37.40% |
| Market Cap | 191.20M |